Acumen Pharmaceuticals Inc
(NAS:ABOS)
$
3.15
0.255 (8.81%)
Market Cap: 189.25 Mil
Enterprise Value: -50.31 Mil
PE Ratio: 0
PB Ratio: 0.72
GF Score: 30/100 Acumen Pharmaceuticals Inc (ABOS) Transcripts
- Q1 2024 Acumen Pharmaceuticals Inc Earnings Call TranscriptMay 14, 2024$3.69 (+9.82%)Earnings
- Q4 2023 Acumen Pharmaceuticals Inc Earnings Call TranscriptMar 26, 2024$3.75 (-11.76%)Earnings
- Acumen Pharmaceuticals Inc at JPMorgan Healthcare Conference TranscriptJan 11, 2024
- Q3 2023 Acumen Pharmaceuticals Inc Earnings Call TranscriptNov 13, 2023$2.03 (+6.84%)Earnings
- Acumen Pharmaceuticals Inc at UBS BioPharma Conference TranscriptNov 09, 2023
- Q2 2023 Acumen Pharmaceuticals Inc Earnings Call TranscriptAug 08, 2023$7Earnings
- Acumen Pharmaceuticals, Inc. - Special Call TranscriptJul 17, 2023
- Acumen Pharmaceuticals Inc at Bank of America Global Healthcare Conference TranscriptMay 11, 2023
- Q1 2023 Acumen Pharmaceuticals Inc Earnings Call TranscriptMay 09, 2023$5.73 (+18.14%)Earnings
- Q4 2022 Acumen Pharmaceuticals Inc Earnings Call TranscriptMar 27, 2023$4.21 (+7.40%)Earnings
- Q2 2022 Acumen Pharmaceuticals Inc Earnings Call TranscriptAug 15, 2022$5.41 (+0.19%)Earnings
- Q1 2022 Acumen Pharmaceuticals Inc Earnings Call TranscriptMay 16, 2022Earnings
- 1